Enzyme-Antibiotic Combo May Combat Ventilator-associated PneumoniaÂ
A new model shows that combining antibiotics with enzymes improved the removal of tough biofilms in VAP, a finding that could lead to more effective treatments.
Tag: hospital-acquired infections
All
Latest
All
Latest
New Hybrid Fungus Found in Hospitals Linked to Lung Disease
Researchers discovered a new Aspergillus hybrid that is found in medical settings and can infect human lungs.
All
LatestAlgorithm IDs Pneumonia Risks
A study published in Chest outlines a new data-driven algorithm that can identify patients at increased risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP).
Aridis Pharma Gets FDA Fast Track for VAP Treatment
Aerucin is a fully human monoclonal antibody for the treatment of hospital-acquired and ventilator-associated pneumonia caused by P. aeruginosa.
Read More
Researchers Refute Study Questioning Chlorhexidine Effectiveness on HAI’s
Researchers are refuting a recent JAMA study that found once-daily bathing of patients with chlorhexidine did not reduce hospital-acquired infections.
Read More
RT On-demand Webinar: Reducing & Preventing VAE/VAP
Join RT Magazine on Sept 24th at 2pm ET for a free webinar on reducing and preventing VAE/VAP. Five experts in respiratory care and infectious disease control will discuss research and offer effective and successful strategies.
Read MoreNew Research Estimates VAP Incidence in ICUs
New multinational epidemiological research sponsored by Sanofi Pasteur estimates the incidence of VAP (15.6%) and Pseudomonas aeruginosa VAP (4.1%) in mechanically-ventilated ICU patients, according to KaloBios.
Read More
Silver, Copper May Prevent Nosocomial Infections
Silver and copper may prove key in preventing nosocomial infections, which kill nearly 88,000 per year.
Read More